Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Grip Molecular Technologies
AddedFeb 17, 2024
UpdatedJun 18, 2026
Grip Molecular Technologies

Grip Molecular Technologies

Angel

GRIP Molecular Technologies: Rapid, point-of-care molecular detection of chemical and biological threats.

HQ
Saint Paul, MN, US
Founded
2019
Overview
Compare
Fundraising
Employees
Website

GRIP Molecular Technologies is dedicated to advancing rapid, point-of-care molecular detection of chemical and biological threats. The Minnesota-based company is developing a proprietary electronic biosensor that leverages enhanced-graphene technology to detect a wide range of biomarkers in a single test. Their innovative approach aims to bring lab-quality diagnostics to at-home settings, making advanced healthcare more accessible and efficient.

GRIP Molecular Technologies has achieved significant milestones, including a collaborative development with Molecular Testing Labs to create an at-home disease testing platform. Their breakthrough technology integrates molecular biology with solid-state electronics, positioning them at the forefront of next-generation diagnostics. The company's patented platform exemplifies their commitment to revolutionizing the field of molecular diagnostics.

Grip Molecular Technologies - Similar Companies

HeMemics Biotechnologies logo

HeMemics Biotechnologies

hememics.com

Minute Molecular Diagnostics logo

Minute Molecular Diagnostics

Molecular Detection logo

Molecular Detection

GeneCapture logo

GeneCapture

genecapture.com

Nanopath logo

Nanopath

nanopathdx.com

NanoSpy logo

NanoSpy

nanospyinc.com

HTG Molecular Diagnostics logo

HTG Molecular Diagnostics

htgmolecular.com

Innovative Biosensors logo

Innovative Biosensors

Caspr logo

Caspr

Torus Biosystems logo

Torus Biosystems

OmniVis logo

OmniVis

Gryphon Bio logo

Gryphon Bio

gryphonbio.com

Enumera Molecular logo

Enumera Molecular

eGlint logo

eGlint

Genendeavor logo

Genendeavor

genendeavor.com

Grip Molecular Technologies - Quick Facts

Who are Grip Molecular Technologies' competitors?

Companies similar to Grip Molecular Technologies include HeMemics Biotechnologies, Minute Molecular Diagnostics, Molecular Detection and GeneCapture.

When was Grip Molecular Technologies founded?

Grip Molecular Technologies was founded in 2019.

Where is Grip Molecular Technologies' headquarters located?

Grip Molecular Technologies' headquarters is located in Saint Paul, MN, US.

How much has Grip Molecular Technologies raised to-date?

As of Oct 9, 2020, Grip Molecular Technologies has raised a total of $50k (USD).

How many employees does Grip Molecular Technologies have?

Grip Molecular Technologies has 6 employees as of Feb 5, 2024.

Grip Molecular Technologies - Classification

Industry
  • Hardware
Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
  • Government
Main Product
  • Biosensors
  • Diagnostics
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 5 more industry codes
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified